We Bring Innovation to Healthcare

Antiphospholipid Syndrome

Antiphospholipid Syndrome (APS), also known as Hughes syndrome is an autoimmune disease defined by the development of venous and/or arterial thrombosis, often multiple, and pregnancy morbidity.


Endotelix is fully focused on innovation within the field of antiphospholipid syndrome. As such, our pipeline is centred on two main clinical developmental projects.


These projects, which include diagnostics and treatments, will significantly improve the management of APS and therefore the lives of the patients who suffer from it.


Endotelix offers fast, reliable and specific solutions for clinical APS management, including diagnostic tools and treatments.



© 2017 by Endotelix